Discovery of Substituted (2-Aminooxazol-4-yl)Isoxazole-3-carboxylic Acids as Inhibitors of Bacterial Serine Acetyltransferase in the Quest for Novel Potential Antibacterial Adjuvants

@article{Magalhes2021DiscoveryOS,
  title={Discovery of Substituted (2-Aminooxazol-4-yl)Isoxazole-3-carboxylic Acids as Inhibitors of Bacterial Serine Acetyltransferase in the Quest for Novel Potential Antibacterial Adjuvants},
  author={Joana Magalh{\~a}es and N. Franko and S. Raboni and Giannamaria Annunziato and P. Tammela and A. Bruno and S. Bettati and Stefano Armao and Costanza Spadini and C. S. Cabassi and A. Mozzarelli and Marco Pieroni and B. Campanini and G. Costantino},
  journal={Pharmaceuticals},
  year={2021},
  volume={14}
}
Many bacteria and actinomycetales use L-cysteine biosynthesis to increase their tolerance to antibacterial treatment and establish a long-lasting infection. In turn, this might lead to the onset of antimicrobial resistance that currently represents one of the most menacing threats to public health worldwide. The biosynthetic machinery required to synthesise L-cysteine is absent in mammals; therefore, its exploitation as a drug target is particularly promising. In this article, we report a… Expand
2 Citations

Figures and Tables from this paper

A Competitive O-Acetylserine Sulfhydrylase Inhibitor Modulates the Formation of Cysteine Synthase Complex
Cysteine is the main precursor of sulfur-containing biological molecules in bacteria and contributes to the control of the cell redox state. Hence, this amino acid plays an essential role inExpand
New insights into the structure and function of an emerging drug target CysE
  • D. Verma, Vibha Gupta
  • Medicine
  • 3 Biotech
  • 2021
TLDR
Despite having conserved structure, slight modification in CysE structure lead to altered the regulatory mechanism and hence affects the cysteine production, which makes it a potential target in the quest to develop novel therapeutics to treat multi-drug-resistant bacteria. Expand

References

SHOWING 1-10 OF 54 REFERENCES
Refining the structure−activity relationships of 2-phenylcyclopropane carboxylic acids as inhibitors of O-acetylserine sulfhydrylase isoforms
TLDR
A medicinal chemistry campaign aiming to develop inhibitors of enzymes that synthesise cysteine and belong to the reductive sulphur assimilation pathway, absent in mammals is carried out, with several compounds able to keep nanomolar binding affinity despite the extent of chemical manipulation. Expand
Design and synthesis of trans-2-substituted-cyclopropane-1-carboxylic acids as the first non-natural small molecule inhibitors of O-acetylserine sulfhydrylase
TLDR
The first example of potent non-natural small molecule inhibitors of HiOASS-A, a pyridoxal-5′-phosphate-dependent enzyme responsible for cysteine biosynthesis in many pathological microorganisms, is reported. Expand
Rational Design, Synthesis, and Preliminary Structure-Activity Relationships of α-Substituted-2-Phenylcyclopropane Carboxylic Acids as Inhibitors of Salmonella typhimurium O-Acetylserine Sulfhydrylase.
TLDR
A combination of computational and spectroscopic approaches are used to rationally design, synthesize, and test a series of substituted 2-phenylcyclopropane carboxylic acids that bind to the two S. typhymurium OASS isoforms at nanomolar concentrations. Expand
Structure-guided design of novel thiazolidine inhibitors of O-acetyl serine sulfhydrylase from Mycobacterium tuberculosis.
TLDR
N nanomolar thiazolidine inhibitors of Mycobacterium tuberculosis CysK1 developed by rational inhibitor design are reported, with an IC50 value of 19 nM for the best compound, a 150-fold higher potency than the natural peptide inhibitor. Expand
Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery.
TLDR
Two compounds were found to show high inhibitory activity toward susceptible M. tuberculosis strains and maintained good activity also toward resistant strains, and they were selective over other bacterial species and eukaryotic cells, metabolically stable, and apparently not susceptible to the action of efflux pumps. Expand
2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry.
TLDR
Evaluation of a series of N-substituted 4-phenyl-2-aminooxazoles that, despite being isosteres of a widely used nucleus such as the 2-aminothiazole, have been only seldom explored are reported. Expand
Cyclopropane-1,2-dicarboxylic acids as new tools for the biophysical investigation of O-acetylserine sulfhydrylases by fluorimetric methods and saturation transfer difference (STD) NMR
TLDR
The cyclopropane-1,2-dicarboxylic acids presented herein provide further insights into the binding mode of small molecules to OASS enzymes, making these compounds excellent tools for the development of competition-binding experiments. Expand
Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
TLDR
A medicinal chemistry campaign was initiated in order to increase the activity of the hit compounds and construct a plausible body of structure-activity relationships and some of the molecules synthesized were found to be active toward the persistent phenotype, and, also, toward a panel of resistant strains. Expand
Inhibition of Nonessential Bacterial Targets: Discovery of a Novel Serine O-Acetyltransferase Inhibitor.
TLDR
This work searched for inhibitors of Salmonella serine acetyltransferase (SAT), the enzyme that catalyzes the rate-limiting step of l-cysteine biosynthesis, and identified six compounds that were able to interfere with bacterial growth via SAT inhibition. Expand
Isozyme-Specific Ligands for O-acetylserine sulfhydrylase, a Novel Antibiotic Target
TLDR
Potential inhibitors of O-acetylserine sulfhydrylase via ligand- and structure-based in silico screening of a subset of the ZINC library using FLAP allow to either selectively target the isozyme that predominantly supports bacteria during infection and long-term survival or to completely block bacterial cysteinesynthesis. Expand
...
1
2
3
4
5
...